YU53790A - Postupak za inhibiciju hiv korišćenjem sinergističkih kombinacija nukleozidnih derivata - Google Patents

Postupak za inhibiciju hiv korišćenjem sinergističkih kombinacija nukleozidnih derivata

Info

Publication number
YU53790A
YU53790A YU53790A YU53790A YU53790A YU 53790 A YU53790 A YU 53790A YU 53790 A YU53790 A YU 53790A YU 53790 A YU53790 A YU 53790A YU 53790 A YU53790 A YU 53790A
Authority
YU
Yugoslavia
Prior art keywords
procedure
synergistic combinations
nucleoside derivatives
hiv inhibition
hiv
Prior art date
Application number
YU53790A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
V. Brankovan
R.J. White
Original Assignee
Oncogen Limited Partenship
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen Limited Partenship filed Critical Oncogen Limited Partenship
Publication of YU53790A publication Critical patent/YU53790A/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU53790A 1989-03-17 1990-03-19 Postupak za inhibiciju hiv korišćenjem sinergističkih kombinacija nukleozidnih derivata YU53790A (sh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32493489A 1989-03-17 1989-03-17
US40190889A 1989-09-01 1989-09-01

Publications (1)

Publication Number Publication Date
YU53790A true YU53790A (sh) 1993-05-28

Family

ID=26984692

Family Applications (1)

Application Number Title Priority Date Filing Date
YU53790A YU53790A (sh) 1989-03-17 1990-03-19 Postupak za inhibiciju hiv korišćenjem sinergističkih kombinacija nukleozidnih derivata

Country Status (19)

Country Link
EP (1) EP0464137A4 (xx)
JP (1) JPH04504850A (xx)
KR (1) KR920700653A (xx)
CN (1) CN1045791A (xx)
AU (1) AU5351490A (xx)
CA (1) CA2050473A1 (xx)
DD (1) DD301787A9 (xx)
FI (1) FI914367A0 (xx)
GR (1) GR1000618B (xx)
HU (1) HU208254B (xx)
IL (1) IL93783A0 (xx)
NO (1) NO913659L (xx)
NZ (1) NZ232912A (xx)
OA (1) OA09555A (xx)
PL (1) PL284343A1 (xx)
PT (1) PT93449A (xx)
WO (1) WO1990011081A1 (xx)
YU (1) YU53790A (xx)
ZW (1) ZW3290A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0513917T4 (da) * 1991-05-16 2001-06-25 Glaxo Group Ltd Antivirale kombinationer indeholdende nukleosidanaloger
CA2335617C (en) * 1998-06-24 2009-12-15 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
AU2002255707A1 (en) 2001-03-15 2002-10-03 Trustees Of Boston College, The Selective anti-viral nucleoside chain terminators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001284A1 (en) * 1985-08-26 1987-03-12 United States Of America, Represented By The Unite Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Also Published As

Publication number Publication date
OA09555A (en) 1993-01-31
HUT57988A (en) 1992-01-28
PL284343A1 (en) 1991-06-03
GR1000618B (el) 1992-08-31
NO913659D0 (no) 1991-09-17
EP0464137A1 (en) 1992-01-08
ZW3290A1 (en) 1990-11-07
JPH04504850A (ja) 1992-08-27
CN1045791A (zh) 1990-10-03
CA2050473A1 (en) 1990-09-18
GR900100189A (en) 1990-07-31
NO913659L (no) 1991-10-18
FI914367A0 (fi) 1991-09-17
HU208254B (en) 1993-09-28
PT93449A (pt) 1990-11-07
DD301787A9 (de) 1994-01-13
NZ232912A (en) 1992-06-25
KR920700653A (ko) 1992-08-10
AU5351490A (en) 1990-10-22
EP0464137A4 (en) 1992-01-15
IL93783A0 (en) 1990-12-23
WO1990011081A1 (en) 1990-10-04
HU902898D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
PT100199A (pt) Combinacao antiviral de nucleosidos e processo para a sua preparacao
DE3882985D1 (de) Adenosin-deaminase-stabile anti-retroviral-nukleoside.
MY102693A (en) Antiviral nucleosides
UA29382C2 (uk) Карбоциклічні нуклеозиди 6-заміщеного пурину
DK169991D0 (da) Antivirale forbindelser
YU74992A (sh) Postupak za pravljenje (-)4-amino-5-fluoro-1-(2-hidroksimetil-1,3-oksatiolan-5-il)-(1h)-pirimidin-2-ona
TW371662B (en) Antiviral acyclic phosphonomethoxyalkyl substituted alkenyl purine and pyrimidine derivatives
ES2108969T3 (es) Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales.
CA2063417A1 (en) Antiviral composition
TW366339B (en) Derivatives of benzimidazolyl-cyclopentanediol, -cyclopentanol and -cyclopentenol, and pharmaceutical composition containing the same
ATE131826T1 (de) Anti-hiv pyrimidin nucleoside
IE893991L (en) 2',3'-dideoxypurine nucleoside/purine nucleoside¹phosphorylase inhibitor combination therapy and composition
YU53790A (sh) Postupak za inhibiciju hiv korišćenjem sinergističkih kombinacija nukleozidnih derivata
EP0311107A3 (en) Anti-hiv active 3'-fluoro-purine-2',3'-dideoxyribosides
ES2134259T3 (es) Compuestos antiviricos calanolidas, composiciones y utilizacion de los mismos.
AU4544289A (en) Antiviral 5-propynyl pyrimidine nucleosides
TH10132A (th) การยับยั้งไวรัสที่ทำให้เกิดภูมิคุ้มกันบกพร่องในคน (hiv) โดยการทำงานร่วมกันแบบเสริมของอนุพันธุ์นิวคลีโอไซด์
ECSP993155A (es) Compuestos quimicos